Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2003
06/05/2003WO2003045332A2 Methods and compositions for treating lesions of the respiratory epithelium
06/05/2003WO2003045331A2 Formulations for oral administration of cromolyn sodium
06/05/2003WO2003045330A2 Materials and methods for making improved micelle compositions
06/05/2003WO2003045327A2 Efavirenz tablet formulation having unique biopharmaceutical characteristics
06/05/2003WO2003045326A2 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
06/05/2003WO2003045307A2 Pharmaceutical formulations comprising indolinone derivatives
06/05/2003WO2003045306A2 Phenoxy amine compounds and compositions for delivering active agents
06/05/2003WO2003045305A2 Acetaminophen compositions
06/05/2003WO2003045168A1 Powder formulation comprising conjugated octadecapolyenic acids
06/05/2003WO2003045166A1 Capsule with fast content solubilization and release
06/05/2003WO2003045160A1 Process for preparing chewing gum containing a nutritional supplement
06/05/2003WO2003035043A3 Pharmaceutical formulation comprising more than 15% tamoxifen
06/05/2003WO2003020241A9 Functional powders for oral delivery
06/05/2003WO2003020161A3 Immune modulation device for use in animals
06/05/2003WO2003011266A3 Azalide antibiotic compositions
06/05/2003WO2003005951A3 Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
06/05/2003WO2002074275A3 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces
06/05/2003WO2002074099A3 Polybutene containing chewing gum and confection
06/05/2003WO2002069949A3 Combination therapy for reduction of toxycity of chemotherapeutic agents
06/05/2003WO2002060864A9 Process of obtaining compositions of stable lutein and lutein derivatives
06/05/2003WO2002058712A3 Probiotic compounds derived from lactobacillus casei strain ke01
06/05/2003WO2002045575A3 Multicomponent biodegradable bioadhesive controlled release system for oral care products
06/05/2003WO2002041987A3 Polymeric microspheres
06/05/2003WO2002000191A3 Bdellosomes
06/05/2003US20030105455 Thermally-activated microchip chemical delivery devices
06/05/2003US20030105168 Composition comprising ubiquinone
06/05/2003US20030105157 Aqueous solution of ascorbic acid and method for producing same
06/05/2003US20030105156 Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility
06/05/2003US20030105155 Prostanoic acid derivatives as agents for lowering intraocular pressure
06/05/2003US20030105144 Celecoxib dissolving in polyethylene glycol; antiinflammatory agents, osteoporosis, respiratory system disorders, antitumor agents, analgesics
06/05/2003US20030105141 Mixture containing fatty acid and aromatic amine; administering by mouth; cyclooxygenase enzyme inhibitor
06/05/2003US20030105067 Vitamin D3 analog loaded polymer formulations for cancer and neurodegenerative disorders
06/05/2003US20030105031 Administering therapeutically effective amount of one or more flavonoids and carrier for therapy of reactive and inflammatory dermatoses
06/05/2003US20030105027 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
06/05/2003US20030105007 PDGF-betabeta and fibronectin combined in a solid wound dressing for the treatment of wounds
06/05/2003US20030104992 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
06/05/2003US20030104990 A cyclosporin mixture comprising a carrier select from 1,2-propylene glycol, glycerides and a surfactant; glycerol-transesterified corn oil, drug bioavailability
06/05/2003US20030104983 A continuous infusion solution, consisting of buffer selected from the group TRIS and arginine, a zinc compound and a phenolic preservatives; treating diabetes, hyperglycemia
06/05/2003US20030104982 Array and method for dosing a hormone regulating blood sugar in a patient
06/05/2003US20030104627 Method and an apparatus for generating shockwave, a method and an apparatus for accelerating particles, an apparatus for delivering drugs, and a method and an apparatus for delivering DNA
06/05/2003US20030104601 Chondroitin synthase gene and methods of making and using same
06/05/2003US20030104590 Microfabricated devices for the storage and selective exposure of chemicals and devices
06/05/2003US20030104588 Method and apparatus for manipulation of cells and cell-like structures using focused electric fields in microfludic systems and use thereof
06/05/2003US20030104089 Induced by urethane or by (((4-N-methyl-N-nitrosoamino)-1-(3-pyridyl)-1-butanone)))
06/05/2003US20030104082 Microbe inhibitors comprising antimicrobial isolates, botanical extracts or phytochemicals; also Commiphora myrrha, Commiphora molmol, Commiphora erythraea, sequiterpenes, nutrient, a vitamin, or a vitamin B complex.
06/05/2003US20030104076 Process for preparing dry extracts
06/05/2003US20030104075 Products containing polyphenol (s) and L-arginine to stimulate nitric oxide production
06/05/2003US20030104072 Optimised pellet formulations
06/05/2003US20030104071 Cellulose ether, especially ethyl cellulose, extended release coating
06/05/2003US20030104070 Coated potassium chloride granules and tablets
06/05/2003US20030104068 Micronized freeze-dried particles
06/05/2003US20030104066 Containing soluble additive having particle size of smaller than 50 mu m and a disintegrator; quickly dissolved in the mouth
06/05/2003US20030104065 Method of preparing solid dispersions
06/05/2003US20030104063 Low-solubility drug and a matrix combined with a concentration- enhancing polymer. improves stability and/ or enhances concentration
06/05/2003US20030104062 Shell-and-core dosage form approaching zero-order drug release
06/05/2003US20030104061 Controlled release tramadol preparations with a storage-stable release profile and process for their production
06/05/2003US20030104060 Fenofibrate pharmaceutical composition having high bioavailability
06/05/2003US20030104059 Combination of non-ionic and anionic hydrophilic polymers, especially hydroxypropyl methyl cellulose and sodium carboxymethyl cellulose
06/05/2003US20030104058 Antineoplastic product, use and formulation thereof
06/05/2003US20030104057 Mixed witha polymeric carrier to produce a certain dissolution profile; follows a zero-order release pattern producing flat plasma levels of valproate, once steady-state levels have been achieved; side effect reduction
06/05/2003US20030104056 Delayed release anti-viral product, use and formulation thereof
06/05/2003US20030104055 Antibiotic product, use and formulation thereof
06/05/2003US20030104054 At least three delayed release dosages forms, each of which has a different release profile, with the Cmaxbeing reached in less than about twelve hours after initial release of drug
06/05/2003US20030104053 Drug dispersed in a solid unitary matrix formed of poly(ethylene oxide) and hydroxypropyl methylcellulose.
06/05/2003US20030104052 Matrix of a biocompatible, hydrophilic, erodible polymer with an active agent incorporated therein; polymer swells in water and gradually erodes with contact with gastric fluid
06/05/2003US20030104051 Fenofibrate pharmaceutical composition having high bioavailability
06/05/2003US20030104050 Process for preparing quick dissolving, high loading ribavirin compositions
06/05/2003US20030104049 Metformin Hydrochloride tablets
06/05/2003US20030104048 Pharmaceutical dosage forms for highly hydrophilic materials
06/05/2003US20030104047 Heating a capsule forming composition in a mold, followed by inserting a pestle into the mold to coat the melted capsule forming composition onto the pestle.
06/05/2003US20030104046 High-concentration lidocaine compositions and methods for their preparation
06/05/2003US20030104045 Novel therapeutic binding molecule complexes
06/05/2003US20030104044 Nucleic acid polymer encapsulated in a lipid cationic lipid particle
06/05/2003US20030104043 Topical cream for alleviating spider veins
06/05/2003US20030104041 Transdermal and topical administration of drugs using basic permeation enhancers
06/05/2003US20030104040 Balancing the molecular properties (van der Waals forces and dipole moments) of all the components against those of all the components plus the particular active agent.
06/05/2003US20030104038 Buccally adherent patch that when stimulated (e.g., by the tongue) triggers natural physiological control mechanisms in human cerebral cortex to control the cough reflex.
06/05/2003US20030104032 Solution or suspension polymerization of a monomer on a tissue surface; normalized compliance ratio of the tissue and the material is0.05-3.
06/05/2003US20030104031 Controlled release polymeric compositions of bone growth promoting compounds
06/05/2003US20030104027 Prolonged-release of drugs by in situ stereotaxic implantation in specific loci; implanted microstructures of prevent dispersion from the implant site.
06/05/2003US20030104021 High electrolyte content W/O emulsions for treating irritated/sensitive skins
06/05/2003US20030104020 Chitosan compositions
06/05/2003US20030104018 Skin product having micro-spheres, and processes for the production thereof
06/05/2003US20030104017 One sweetener or flavor masks quick-acting bitterness and another masks long-acting bitterness
06/05/2003US20030104015 Emulsion or micellar solution of alpha-tocopherol, one or more surfactants (e.g., a vitamin E derivative), an aqueous phase, and a therapeutic agent
06/05/2003US20030104010 Novel, non-antigenic, mucosal adjuvant formulation which modulates the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
06/05/2003US20030103995 Detection and therapy of vulnerable plaque with photodynamic compounds
06/05/2003US20030103954 Comprises vitamin D3 for regulating cell differentiation and/or cell proliferation
06/05/2003US20030103953 Comprises vitamin D3 for controlling cell differentiation and/or cell proliferation
06/05/2003US20030103933 Proteins stabilized with polysaccharide gums
06/05/2003US20030103931 Crosslinked polylysine
06/05/2003US20030103914 Oral care compositions
06/05/2003US20030103912 Breaking, disrupting film in aqueous solution; preventioncoagulation
06/05/2003US20030103911 Delivery of hydrogel compositions as a fine mist
06/05/2003US20030103910 Chewing gum
06/05/2003US20030103908 Aerosol form; mixture with sugar and liquid carrier
06/05/2003US20030103907 Suspension aerosol formulations
06/05/2003US20030103906 Controlling releasing of dosage; respiratory system disorders
06/05/2003US20030103864 Sterilization of pharmaceuticals
06/05/2003US20030102246 Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
1 ... 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 ... 2991